with astrocytes removing small dendrites and microglia engulfing and scavenging soma and main processes
We excluded patients with cirrhotic liver, history of gall bladder, biliary disorders, pancreatic diseases, interrupted use of GLP-1RAs throughout the study period, and patients used other drugs with potential effects on the motility of biliary tracts such as cholecystokinin, motilin hormone, cholinomimetic agents like prostigmine, erythromycin, cisapride, cholystyramine, intravenous aminoacids, cholinergic agents like atropine, somatostatin, and progesterone, trimebutine, loperamide and ondansetron
The nutritional principles remain the same at every dose
See our how to get retatrutide guide for the full FDA timeline, clinical trial enrollment steps, and what alternatives are available now
This area can be hard to see and reach correctly on your own